Colgate-Palmolive (India) Ltd, or CPIL, is a 51% subsidiary of Colgate-Palmolive Company, USA. It is the market leader in Indian oral care market. In FY15, it commanded 57.8% & 42.1% volume market share in toothpaste & toothbrush category respectively. CPIL has maintained its position as the undisputed leader for more than a decade.
Valuation and View
CPIL is better placed than peers given its strong parentage, pricing power, leadership position and distribution reach in the oral care market. We expect revenue and PAT to grow at a CAGR of 9.6% and 11.4% over FY15-FY18E. Further, we rate the stock as ‘BUY’ assigning a forward P/E of 33x arriving at a target price of Rs. 937 which implies potential upside of ~10% for next 12 months.
Research Report Colgate-Palmolive (India)Ltd
Investments in equity shares, debentures, etc., are not obligations of, or guaranteed by Wealth India Financial Services Pvt. Ltd., and are subject to investment risks. Click here to read our full disclaimer.
- Merger of Navi Overnight Fund into Navi Liquid Fund and Navi Conservative Hybrid Fund into Navi Aggressive Hybrid Fund
- Intimation of suspension of subscription in Bandhan US Equity Fund of Fund
Winning Funds, Losing Streaks: Decoding the Mystery of Short-Term Underperformance
Wealth Conversations – November 2024- Notice of Change in Fundamental Attributes of DSP Equity & Bond Fund and DSP Quant Fund
